BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
gian life care limited stock

Gian Life Care Limited Share Price

19.66 -0.57 (-2.81%)
Dec 13 2024 03:30 PM Healthcare NSE: GIANLIFE

Gian Life Care Limited Share Price Update

As of the latest trading session, Gian Life Care Limited share price is currently at 19.66, which is down by -0.57 from its previous closing. Today, the stock has fluctuated between 19.15 and 20.83. Over the past year, Gian Life Care Limited has achieved a return of -5.79 %. In the last month alone, the return has been -4.33 %. Read More...

Gian Life Care Limited Performance

Day Range

Low19.15 High20.83
19.66

52 Week Range

Low 17.01 High 29.00
19.66

Gian Life Care Limited Share Price

542918

GIANLIFE

img img img img
No Data Available

Open Price

20.01

Prev. Close

20.24

Volume (Shares)

20299.00

Total traded value

3.99

Upper Circuit

24.28

Lower Circuit

16.20

Note: The current prices & values are delayed, Login to your account for live updates.

Gian Life Care Limited Fundamentals


(Standalone)

Market Cap (Cr) 20.33
PE Ratio (TTM) 4.99
Book Value / Share 19.21
Beta 0.62
ROE 24.63%
EPS (TTM) 3.94
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.14

Gian Life Care Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 1.95
Operating Expense 1.94
Net Profit 0.14
Net Profit Margin (%) 7.17
Earnings Per Share (EPS) 0.14
EBITDA 0.39
Effective Tax Rate (%) 17.64
Particulars JUN 2024 (Values in Cr)
Revenue 1.98
Operating Expense 1.99
Net Profit 0.11
Net Profit Margin (%) 5.55
Earnings Per Share (EPS) 0.10
EBITDA 0.40
Effective Tax Rate (%) 35.29
Particulars MAR 2024 (Values in Cr)
Revenue 4.60
Operating Expense 1.68
Net Profit 2.20
Net Profit Margin (%) 47.82
Earnings Per Share (EPS) 2.13
EBITDA 3.28
Effective Tax Rate (%) 29.26
Particulars DEC 2023 (Values in Cr)
Revenue 3.79
Operating Expense 1.79
Net Profit 1.63
Net Profit Margin (%) 43.00
Earnings Per Share (EPS) 1.57
EBITDA 2.40
Effective Tax Rate (%) 24.53
Particulars SEP 2023 (Values in Cr)
Revenue 2.30
Operating Expense 2.21
Net Profit 0.20
Net Profit Margin (%) 8.69
Earnings Per Share (EPS) 0.20
EBITDA 0.48
Effective Tax Rate (%) 16.66
Particulars MAR 2024 (Values in Cr)
Revenue 13.12
Operating Expense 7.85
Net Profit 4.30
Net Profit Margin (%) 32.77
Earnings Per Share (EPS) 4.16
EBITDA 6.82
Effective Tax Rate (%) 27.41
Particulars MAR 2023 (Values in Cr)
Revenue 11.92
Operating Expense 10.84
Net Profit 1.26
Net Profit Margin (%) 10.57
Earnings Per Share (EPS) 1.22
EBITDA 2.72
Effective Tax Rate (%) 29.60
Particulars MAR 2022 (Values in Cr)
Revenue 15.93
Operating Expense 10.58
Net Profit 4.37
Net Profit Margin (%) 27.43
Earnings Per Share (EPS) 4.23
EBITDA 6.52
Effective Tax Rate (%) 25.29
Particulars MAR 2021 (Values in Cr)
Revenue 10.46
Operating Expense 7.99
Net Profit 2.02
Net Profit Margin (%) 19.31
Earnings Per Share (EPS) 4.29
EBITDA 3.34
Effective Tax Rate (%) 26.90
Particulars MAR 2020 (Values in Cr)
Revenue 7.65
Operating Expense 6.18
Net Profit 1.13
Net Profit Margin (%) 14.77
Earnings Per Share (EPS) 3.13
EBITDA 2.12
Effective Tax Rate (%) 27.56
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.64
ROE % 24.13
ROCE % 27.80
Total Debt to Total Equity 0.27
EBITDA Margin 51.98
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.62
ROE % 7.27
ROCE % 11.22
Total Debt to Total Equity 0.23
EBITDA Margin 21.31
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.56
ROE % 31.15
ROCE % 38.66
Total Debt to Total Equity 0.14
EBITDA Margin 41.24
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.97
ROE % 24.63
ROCE % 28.36
Total Debt to Total Equity 0.25
EBITDA Margin 52.13
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.81
ROE % 8.59
ROCE % 12.25
Total Debt to Total Equity 0.23
EBITDA Margin 22.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.57
ROE % 36.89
ROCE % 46.55
Total Debt to Total Equity 0.13
EBITDA Margin 41.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 20.54
ROE % 23.35
ROCE % 32.06
Total Debt to Total Equity 0.12
EBITDA Margin 32.41
Particulars MAR 2020 (Values in Cr)
Book Value / Share 16.25
ROE % 29.16
ROCE % 37.88
Total Debt to Total Equity 0.31
EBITDA Margin 28.50
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.98
Total Assets 32.63
Total Liabilities 32.63
Total Equity 19.27
Share Outstanding 10341524
Price to Book Ratio 1.29
Return on Assets (%) 12.72
Return on Capital (%) 17.19
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.76
Total Assets 28.24
Total Liabilities 28.24
Total Equity 15.11
Share Outstanding 10341524
Price to Book Ratio 1.15
Return on Assets (%) 3.76
Return on Capital (%) 5.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.85
Total Assets 23.06
Total Liabilities 23.06
Total Equity 14.02
Share Outstanding 10341524
Price to Book Ratio 3.06
Return on Assets (%) 18.95
Return on Capital (%) 27.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 5.97
Total Assets 32.07
Total Liabilities 32.07
Total Equity 19.61
Share Outstanding 10341524
Price to Book Ratio 1.29
Return on Assets (%) 13.39
Return on Capital (%) 18.06
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.75
Total Assets 28.40
Total Liabilities 28.40
Total Equity 15.31
Share Outstanding 10341524
Price to Book Ratio 1.15
Return on Assets (%) 4.42
Return on Capital (%) 6.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.74
Total Assets 23.05
Total Liabilities 23.05
Total Equity 14.03
Share Outstanding 10341524
Price to Book Ratio 3.06
Return on Assets (%) 18.97
Return on Capital (%) 27.51
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.51
Total Assets 15.47
Total Liabilities 15.47
Total Equity 9.65
Share Outstanding 4700694
Price to Book Ratio 0.66
Return on Assets (%) 13.03
Return on Capital (%) 19.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.12
Total Assets 12.37
Total Liabilities 12.37
Total Equity 7.63
Share Outstanding 4700694
Price to Book Ratio 0.81
Return on Assets (%) 9.10
Return on Capital (%) 13.37
Particulars MAR 2024 (Values in Cr)
Net Income 5.74
Cash from Operations 0.71
Cash from Investing -0.31
Cash from Financing -0.16
Net change in Cash 0.22
Free Cash Flow 1.69
Particulars MAR 2023 (Values in Cr)
Net Income 1.59
Cash from Operations 2.24
Cash from Investing -0.94
Cash from Financing -0.36
Net change in Cash 0.91
Free Cash Flow 3.87
Particulars MAR 2022 (Values in Cr)
Net Income 5.84
Cash from Operations 6.46
Cash from Investing -4.12
Cash from Financing 0.67
Net change in Cash 2.34
Free Cash Flow 7.42
Particulars MAR 2024 (Values in Cr)
Net Income 5.91
Cash from Operations 0.76
Cash from Investing 0.32
Cash from Financing -0.85
Net change in Cash 0.22
Free Cash Flow 1.07
Particulars MAR 2023 (Values in Cr)
Net Income 1.78
Cash from Operations 2.33
Cash from Investing -0.94
Cash from Financing -0.36
Net change in Cash 1.00
Free Cash Flow 3.97
Particulars MAR 2022 (Values in Cr)
Net Income 5.85
Cash from Operations 6.46
Cash from Investing -4.23
Cash from Financing 0.67
Net change in Cash 2.23
Free Cash Flow 7.42
Particulars MAR 2021 (Values in Cr)
Net Income 2.75
Cash from Operations 3.16
Cash from Investing -1.09
Cash from Financing -0.38
Net change in Cash 1.38
Free Cash Flow 3.59
Particulars MAR 2020 (Values in Cr)
Net Income 1.55
Cash from Operations 1.73
Cash from Investing -3.96
Cash from Financing 2.55
Net change in Cash 0.09
Free Cash Flow 1.91
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 88.28 13.93 104442.30 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.05 0.00 3.89 116.29 44.00 / 107.94
SHREE PACETRONIX LTD. 123.75 19.93 3.31 44.54 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.60 0.00 5.31 57.59 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 93.01 12.75 104442.30 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 52.25 0.00 -27.99 39.03 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5501.45 29.84 6.18 6018.59 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 20.10
  • 26 Days 20.10
  • 10 Days 20.30
  • 50 Days 20.30
  • 12 Days 20.10
  • 100 Days 21.10
  • 20 Days 20.10
  • 200 Days 24.80
20.36
PIVOT
First Resistance 20.71
Second Resistance 21.19
Third Resistance 21.54
First Support 19.88
Second Support 19.53
Third Support 19.05
RSI 45.86
MACD -0.02
Commodity Channel Index (CCI) 2.28
ADX 28.93
Williams % R -54.74

Over 1 Month

down

-4.33

Over 3 Months

down

-14.59

Over 6 Months

down

-13.00

Over 1 Year

down

-5.79

Over 3 Years

down

-19.75

Over 5 Years

down

14.47

Gian Life Care Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Gian Life Care Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
68.01
Promoter Holdings
31.98
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
62.27
Name Category Shares Shares%
Arun Kumar Gupta Shareholding of Promoter and Promoter Group 2988148.0 28.89
Shield Multistate Cooperative Credit Public Shareholding 670650.0 6.49
Sundiip Devaadigaa Public Shareholding 381968.0 3.69
Tejesh Hasmukh Shah Public Shareholding 376101.0 3.64
N Mohan Neela Judith Public Shareholding 286052.0 2.77
Avani Gupta Shareholding of Promoter and Promoter Group 232100.0 2.24
Prashant Prithviraj Jain Public Shareholding 114622.0 1.11
Rahul Govind Binnani Public Shareholding 110000.0 1.06
Rashika Agarwal Shareholding of Promoter and Promoter Group 43780.0 0.42
Devang Agarwal Shareholding of Promoter and Promoter Group 43780.0 0.42
Akanksha Gupta Shareholding of Promoter and Promoter Group 437.0 0.0

Gian Life Care Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
2022-03-30 2022-03-29 6:5
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Gian Life Care Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Gian Life Care Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Gian Lifecare Ltd?

Answer Field

The share price of Gian Lifecare Ltd for NSE is ₹ 0.00 and for BSE is ₹ 19.66.

What is the Market Cap of Gian Lifecare Ltd?

Answer Field

The market cap of Gian Lifecare Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 20.30 Cr. as of now.

What is the 52 Week High and Low of Gian Lifecare Ltd?

Answer Field

The 52 Week High and Low of Gian Lifecare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 29.00 and ₹ 17.01.

How to Buy Gian Lifecare Ltd share?

Answer Field

You can trade in Gian Lifecare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Gian Lifecare Ltd?

Answer Field

The 1 year returns on the stock has been -5.79%.

What is the Current Share Price of Gian Lifecare Ltd?

Answer Field

Gian Lifecare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 19.66 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Gian Lifecare Ltd Share?

Answer Field

The market cap of Gian Lifecare Ltd for NSE ₹ 0.0 & for BSE ₹ 20.30 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Gian Lifecare Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Gian Lifecare Ltd share is 4.99.

What is the PB ratio of Gian Lifecare Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Gian Lifecare Ltd share is 19.21.

How to Buy Gian Lifecare Ltd Share?

Answer Field

You can trade in Gian Lifecare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gian Lifecare Ltd Share on Bajaj Broking App?

Answer Field

To buy Gian Lifecare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gian Lifecare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader